Engineered oncolytic bacteria have emerged as a promising therapeutic platform for precision cancer treatment, offering tumor-specific colonization, immune activation, and controllable therapeutic delivery. This review summarizes recent advances in the design and application of synthetic biologic... Read more
Medical News - Dec 13
WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) has entered into an exclusive option agreement with Incyte Corporation (Nasdaq: INCY) for its mutant-selective JAK2V617F JH2 inhibitor program, a next-generation therapy ... Read more
Mychesco - Nov 11
The clinical-stage biopharma stock has rallied more than 70% over the past three months on the back of promising clinical data for its lead drug, Palazestrant. Read more
Cnbc - Oct 30
Getting a COVID shot might do more than protect against the virus – it could also help cancer patients live longer. A new study found that mRNA vaccines were linked to a doubling in three-year survival for those on immunotherapy.Continue ReadingCategory: Illnesses and conditions, Body and MindTag... Read more
New Atlas - Oct 24
Treatments for cancer are continuously improving, but they can still cause debilitating, even fatal, side effects. Read more
Medical News - Oct 10
